What does HeXun Biosciences Co., Ltd. do?

HeXun Biosciences Co., Ltd. (6986.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6986.TWO's market cap?

HeXun Biosciences Co., Ltd. (6986.TWO) has a market capitalization of approximately $2.18 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6986.TWO pay a dividend?

Yes — HeXun Biosciences Co., Ltd. (6986.TWO) pays a dividend irregular, with a trailing-twelve-month yield of 0.46%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

6986.TWO

HeXun Biosciences Co., Ltd.

TWO·Biotechnology · Healthcare

NT$41.75NT$0.55−1.30%

Market capNT$2.18B·Aug 26 5:30 AM UTC

Price Chart

NT$41.75−NT$0.55 (−1.30%)today

−53.82%CAGR −22.92%

Select date range

FromTo

Sep 7, 2023Sep 7, 2023 → Aug 26, 2026· 3.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.46%

Annual Dividend (FWD)NT$0.19

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio35.9%

FCF Payout Ratio6.8%

Most Recent DividendNT$0.194

Ex-Dividend DateAug 18

Payment DateSep 17

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−30.4%

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 12

Last Report DateMay 13

Reported vs EstimateNT$0.54

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$308.21M

Net IncomeNT$116.33M

Net Margin37.7%

Operating Cash FlowNT$163.75M

Capital ExpendituresNT$30.73M

Free Cash FlowNT$133.02M

Return on Equity10.9%

Return on Invested Capital3.4%

Net CashNT$794.27M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6986.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6986.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6986.TWO and 80,000+ other tickers.

About HeXun Biosciences Co., Ltd.

HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research, development, and application of stem cell technologies and treatments. The company also offers a comprehensive suite of related services, including contract development and manufacturing for various cell types and their derivatives, outsourced production capabilities, quality control inspections, expert consulting, laboratory information management system (LIMS) implementation, and sterile (aseptic) filling solutions. Founded in 2019, its operations are headquartered in Taoyuan City, Taiwan.

CEO: Ji-Hong Huang
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 53
Website: www.hexunbio.com

Peers

Peers Tab

6704.TWO

Gwo Xi Stem Cell Applied Technology Co. , Ltd

Cap

NT$1.8B

7729.TWO

Steminent Biotherapeutics Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6986.TWO

What does HeXun Biosciences Co., Ltd. do?: HeXun Biosciences Co., Ltd. (6986.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6986.TWO's market cap?: HeXun Biosciences Co., Ltd. (6986.TWO) has a market capitalization of approximately $2.18 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6986.TWO pay a dividend?: Yes — HeXun Biosciences Co., Ltd. (6986.TWO) pays a dividend irregular, with a trailing-twelve-month yield of 0.46%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.